Janssen Biotech, Inc.

Janssen Pharmaceutica Nv

Jingli Wang

Peter A Krulevitch

Lorin Philip Olson

Nicholas Foley

Mingqi Zhao

Michael G Cannamela

James Glencross

Paul Tashjian

Juergen Pfrang

Vaclav Vojan

Hong Yan

Rochelle Kleinberg

Nick Foley

Richard K Tanaka

Ian Scrimgeour

Steven M Vesole

Emma Louise Hubert

Monica A Kapil

Jimmy Vinh Hoang Cassebee

David Ramos

Dolores PÉREZ

Juergen E Pfrang

A device configured to administer a medication can comprise a lower housing that includes a housing latch. The device can further comprise a needle guard that is movable relative to the lower housing along a first direction from a first position to a second position so as to expose a needle, and an upper housing supported relative to the lower housing. The upper housing can be configured to move with respect to the lower housing along a second direction from a pre-use position to a dispensed position. The housing latch can releasably interfere with the upper housing when the upper housing is in the pre-use position so as to prevent the upper housing from moving toward the dispensed position, and the movement of the needle guard toward the second position, causes the interference to be removed, thereby allowing the upper housing to move toward the second position.

Palm activated drug delivery device

Intranasal drug delivery device

The present invention provides devices and methods for treating depression in a patient, comprising administering to the patient in need of the treatment a therapeutically effective amount of esketamine. In some embodiments, the depression is major depressive disorder or treatment resistant depression. In other embodiments, the therapeutically effective amount is clinically proven safe and/or effective. Also provided are methods to mitigate the risk or misuse or abuse of esketamine, instructions for use of the esketamine product, and methods for selling a drug product containing esketamine.

Delivery of esketamine for the treatment of depression

Disclosed is a device for the parenteral delivery of a medication, such as a drug. The device includes upper and lower housings in which the upper housing is configured to move relative to the lower housing as a result of application of an external force to permit the user of the device to control the rate at which the drug is administered.

Growing community of inventors

San Jose, CA, United States of America

Jingli Wang